Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- ChecktodayChange DetectedUpdated page revision from v3.4.0 to v3.4.1; no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoChange DetectedUI and metadata updates were made: glossary toggle added, QC criterion label capitalization adjusted, and new No FEAR Act Data and Revision: v3.4.0 notes; some items removed or renamed (No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor system update and does not affect study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedA consolidated Locations section now lists Ontario and Quebec as study sites, replacing the previous separate location headings; the page revision shows Revision: v3.3.3.SummaryDifference0.4%

- Check72 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the government funding lapse notice and related operating-status information from the page.SummaryDifference0.4%

Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.